Page last updated: 2024-11-09

6,8-difluoro-4-methylumbelliferyl phosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

6,8-difluoro-4-methylumbelliferyl phosphate: a fluorescent substrate of protein phosphatases 1 and 2A [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID2786976
CHEBI ID133848
SCHEMBL ID329996
MeSH IDM0305454

Synonyms (16)

Synonym
214491-43-7
6,8-difluoro-4-methylumbelliferyl phosphate
CHEBI:133848
(6,8-difluoro-4-methyl-2-oxochromen-7-yl) dihydrogen phosphate
SCHEMBL329996
[(6,8-difluoro-4-methyl-2-oxo-2h-chromen-7-yl)oxy]phosphonic acid
bdbm13432
difmup
6,8-difluoro-4-methyl-umbelliferyl phosphate
6,8-difluoro-4-methyl-2-oxo-2h-chromen-7-yl dihydrogen phosphate
DTXSID101261252
6,8-difluoro-4-methyl-7-(phosphonooxy)-2h-1-benzopyran-2-one
HY-120166
6,8-difluoro-4-methyl-2-oxo-2h-chromen-7-yldihydrogenphosphate
CS-0077049
AKOS040751567
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
coumarins
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (14.29)18.2507
2000's6 (42.86)29.6817
2010's6 (42.86)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 17.28

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index17.28 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.81 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (17.28)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (7.14%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (92.86%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]